Skip to main content

Table 5 Comparison of clinical and laboratory outcomes of severe HFMD with prolonged hyperthermia, and/ or neurological manifestations treated with or without IVIG

From: Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China

Variable

IVIG (47)

M (IQR)

Without IVIGa (31)

M (IQR)

Z

P

Fever

1 (1,1)

4 (4,4)

−9.971

< 0.001

Vomiting

2 (2,2)

3 (3,3)

−8.596

< 0.001

Startle

2 (2,2)

3 (3,4)

−9.711

< 0.001

Myoclonic twitching

2 (2,2)

4 (3.5,4)

−9.483

< 0.001

WBC (> 15 × 109/L)

2 (2,2)

3 (3,3.5)

−9.729

< 0.001

CRP (> 40 mg/L)

2 (2,2)

4 (4,4)

−10.489

< 0.001

Length of stay (day)

4 (4,5)

5 (5,6)

−6.651

< 0.001

  1. Abbreviations: M median, IQR interquartile range, IVIG intravenous gamma globulin intervention. aSubjects with prolonged hyperthermia, and/ or neurological manifestations refused to receive IVIG because of the cost or safety issue